Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Scabies is an invasive skin condition caused by Sarcoptes scabiei mites. The present study investigates the antiscabies potential of coconut seed extract (CSE) in rabbits. GC-MS analysis of the seed oil identified 17 known compounds, while CSE phytochemical investigation afforded 4 known ones. The topical application of seed extract improved all signs of infection, and the improvement started 3 days post application. However, in vitro application of the extract caused 99% mortality of mites 1 day post application. Histopathological examination revealed the absence of inflammatory infiltration and hyperkeratosis of the epidermis, compared with ivermectin-treated groups which revealed less improvement. The mRNA gene expression results revealed a suppression of IL-1β, IL-6, IL-10, MMP-9, VEGF, and MCP-1, and an upregulation of I-CAM-1, KGF as well as TIMP-1. The docking analysis emphasized a strong binding of gondoic acid with IL-1β, IL-6, and VEGF with high binding scores of −5.817, −5.291, and −8.362 kcal/mol, respectively, and a high binding affinity of 3″(1‴-O-β-D-glucopyranosyl)-sucrose with GST with −7.24 kcal/mol. Accordingly, and for the first time, our results highlighted the scabicidal potential of coconut seed extract, which opens the gate for an efficient, cost-effective as well as herbal-based alternative for the control of scabies in rabbits.

Details

Title
Scabicidal Potential of Coconut Seed Extract in Rabbits via Downregulating Inflammatory/Immune Cross Talk: A Comprehensive Phytochemical/GC-MS and In Silico Proof
Author
Eman Maher Zahran 1   VIAFID ORCID Logo  ; Reda Abdel-Maqsoud, Nehad M 2 ; Tammam, Omar Y 3 ; Abdel-Rahman, Islam M 4   VIAFID ORCID Logo  ; Elrehany, Mahmoud A 3 ; Bakhsh, Hussain T 5   VIAFID ORCID Logo  ; Altemani, Faisal H 6   VIAFID ORCID Logo  ; Algehainy, Naseh A 6   VIAFID ORCID Logo  ; Alzubaidi, Mubarak A 7   VIAFID ORCID Logo  ; Usama Ramadan Abdelmohsen 8   VIAFID ORCID Logo  ; Elmaidomy, Abeer H 9 

 Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt 
 Department of Pathology, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt; Department of Pathology, Faculty of Medicine, Minia University, Minia 61519, Egypt 
 Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt 
 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt 
 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia 
 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
 Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt; Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt 
 Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt 
First page
43
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
20796382
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2767127314
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.